findmyKOL
Clinical trialNCT05022875UnknownInterventional

Effectiveness of The Health Care CEO App for T1D

SponsorChang Gung UniversityEnrollment96Type 1 Diabetes Mellitus
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Taiwan
  • Chang-Gung University and Chang-Gung Memorial Hospital

    Taoyuan, Taiwan

    Chi An, PhD.Chi-Wen Chang, PhD.Chi-wen Chen, PhD.Chienlung Hsu, PhD.Fu-Sung Lo, BSNHsing-Yi Yu, PhD.Pei-kwei Tsay, PhD.Philip Moons, PhD.Yueh-Tao Chiang, PhD.
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
23 Apr 2021
Primary completion
31 Jul 2022
Completion
31 Jul 2022
Last update posted
26 Aug 2021
Registered enrollment
96
Registry id
NCT05022875

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.